Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 77 clinical trials
featured
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive patients With Impaired Glucose Tolerance or Impaired Fasting Glucose

The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive patients With Impaired Glucose Tolerance or Impaired Fasting Glucose

  • 102 views
  • 08 Nov, 2020
  • 1 location
featured
Do you think you're having difficulty controlling your high blood pressure?

Do you think you're having difficulty controlling your high blood pressure?

  • 373 views
  • 08 Nov, 2020
  • 1 location
featured
Marfan Syndrome (MFS) Medication Study

Marfan Syndrome (MFS) Medication Study

  • 88 views
  • 25 Mar, 2021
  • 1 location
Evaluation of Early CRRT InTerventions in Patients With ECMO(ELITE)

the cardiac myocardium. Beta-blockers can antagonize the effects of catecholamine. In patients with VA-ECMO, the protective effect of beta-blocker may improve the patients' outcome. This hypothesis

  • 0 views
  • 23 Jan, 2021
  • 1 location
Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina

This is a multi-center, double-blind, randomized, placebo-controlled, parallel-group phase 3 clinical study to confirm the safety and efficacy of T89 in patients with stable angina pectoris, with an extended open-label period to evaluate the long-term safety of T89. This study includes three main periods: the first study period is a …

  • 0 views
  • 27 Jan, 2021
  • 1 location
Does Propranolol a Beta Blocker Attenuate Stress-Induced Drinking?

For this protocol, the investigators plan to conduct a pilot study evaluating the effect of propranolol on alcohol consumption. Using a parallel design, the investigators plan to randomize 20 non-treatment seeking adults with alcohol use disorders (DSM-5) to propranolol extended release (160mg/day or placebo; n=10 per cell) to evaluate whether …

  • 11 views
  • 17 Jul, 2021
  • 1 location
Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis

Clinical study evaluating selective or nonselective beta blockers use and fracture risk in patients with primary osteoporosis

  • 3 views
  • 30 Jan, 2021
  • 1 location
Metoprolol and Formoterol in Chronic Obstructive Pulmonary Disease (COPD)

We want to study the effect of the combination of metoprolol (a beta-blocker) with formoterol (a beta-agonist) on long function in patients with Chronic Obstructive Pulmonary Disease

pulmonary function test
formoterol
  • 26 views
  • 07 Nov, 2020
  • 1 location
Atenolol for the Prevention of Osteoporosis (APO)

Evaluate whether treatment with a widely used beta blocker, atenolol, will prevent bone loss at the lower back and hip in postmenopausal women.

  • 10 views
  • 06 Aug, 2021
  • 1 location
Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients

. Propranolol, a beta-blocker, is a potentially useful therapeutic considering its anti-angiogenic properties. Our objective is to explore the efficacy of propranolol, three months after its introduction, on

recurrent nosebleeds
arteriovenous malformation
angiogenesis
epistaxis
genetic disorder
  • 0 views
  • 24 Jan, 2021
  • 1 location